Though the frequency of EGFR KDD may be underestimated due to the technical difficulty, it has only been reported in a limited number of entities since the initial description in 1998, with the reported highest frequency being 0.2% in lung adenocarcinoma [7,8]. This evidence concerns the gene EGFR and lung adenocarcinoma.